The Munich Biotech Mafia expand to the US with a New TCR Startup
TCR2 Therapeutics was backed by the Munich biotech mafia, a group of wealthy veteran biotech…
December 8, 2016 - 2 minutes
Cell therapy
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
Meet the CEO making the Next Generation of Gene Therapies Possible
How do you solve a problem like lentiviral vector infections? CEVEC has done it. We…
November 16, 2016 - 6 minutes
Cell Therapies: Is Commercialization holding back a Breakthrough?
How far away is biotech from a breakthrough with cell and gene therapy? While these…
November 16, 2016 - 4 minutes
UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials
The FDA puts one of Adaptimmune's TCR trials on a partial hold, pending more information…
November 10, 2016 - 3 minutes
European Biotech is working hard to Beat back Melanoma
Immunocore and Pierre Fabre have been representing Europe in this years' Society for Melanoma Research Congress.…
November 10, 2016 - 3 minutes
TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer
Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some…
October 28, 2016 - 2 minutes
This Technology Opens new Horizons for Protein Production
Based in Cologne, Germany, Cevec focuses on human cell-based expression system for production of biological therapies.…
October 19, 2016 - 5 minutes
Adaptimmune Revises TCR Protocol following Phase I/IIa Failure
Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to…
October 13, 2016 - 2 minutes
Titans in Gene Therapy and TCRs make a Massive Deal
Medigene has licensed a few candidates from its TCR platform to one of the Boston…
September 29, 2016 - 3 minutes
How did Cancer Cell Therapy become reality?
Using the body's own tools to eradicate cancers has been a dream of Medicine for…
August 16, 2016 - 3 minutes
UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease
Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position…
August 3, 2016 - 3 minutes
Takeda snatches up Belgian Cell therapy for Crohn’s Disease
TiGenix is licensing the rights for its cell therapy which is under EMA review and…
July 6, 2016 - 3 minutes
